Echocardiography in Patients With Covid-19
Sponsor
University Hospital Tuebingen (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04412460
Collaborator
(none)
0
1
21.4
0
Study Details
Study Description
Brief Summary
Prospective observational study of patients treated due to Covid-19 disease. Observation and analysis of echocardiographic studies performed in the intensive care setting.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Echocardiography in Patients With Covid-19 Undergoing Intensive Care Therapy
Actual Study Start Date
:
Mar 20, 2020
Anticipated Primary Completion Date
:
Dec 31, 2021
Anticipated Study Completion Date
:
Dec 31, 2021
Outcome Measures
Primary Outcome Measures
- ICU Mortality [up to 90 days]
Secondary Outcome Measures
- ICU length-of stay [up to 90 days]
- ICU ventilator free days [up to 90 days]
- Hospital length-of-stay [up to 90 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age above 18 years
-
Covid-19 disease
-
invasive Ventilation
Exclusion Criteria:
- none
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Tubingen | Tubingen | BW | Germany | 72076 |
Sponsors and Collaborators
- University Hospital Tuebingen
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT04412460
Other Study ID Numbers:
- CovidEcho
First Posted:
Jun 2, 2020
Last Update Posted:
Sep 30, 2021
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: